Cocrystal Pharma (COCP) Expected to Announce Quarterly Earnings on Wednesday

Cocrystal Pharma (NASDAQ:COCP) is expected to issue its results before the market opens on Wednesday, November 12th. Analysts expect the company to announce earnings of ($0.21) per share for the quarter.

Cocrystal Pharma (NASDAQ:COCP) last released its earnings results on Thursday, August 14th. The company reported ($0.20) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.30) by $0.10. On average, analysts expect Cocrystal Pharma to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Cocrystal Pharma Price Performance

COCP opened at $1.10 on Monday. Cocrystal Pharma has a 12 month low of $1.00 and a 12 month high of $3.26. The business has a 50-day moving average of $1.23 and a two-hundred day moving average of $1.46. The stock has a market capitalization of $11.30 million, a price-to-earnings ratio of -0.89 and a beta of 2.24.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Cocrystal Pharma in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $6.00.

About Cocrystal Pharma

Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.